Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ENDOCYTE INCECYT · Entity 161591 | Director | May 04, 2017 | May 05, 2017 |
| HTG MOLECULAR DIAGNOSTICS, INCHTGM · Entity 112530 | Director | September 15, 2022 | September 15, 2022 |
| SCYNEXIS INCSCYX · Entity 7194 | Director | June 26, 2026 | June 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ENDOCYTE INC
Report date May 04, 2017 · Filed May 05, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,800 |
Reported balance
After 2017-05-04 transaction · row 1
1 source rowRow 1 · 2017-05-04 · Grant · Acquired 3,300 · Balance 7,800 F1: Represents restricted stock units that will vest 100% on the business day prior to the next annual stockholder meeting following the date of grant, and will be paid in the form of one share of common stock for each restricted stock unit. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.27 · Expires 2027-05-04 | Direct | 19,500 |
Reported balance
After 2017-05-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-05-04 · Grant · Acquired 19,500 · Balance 19,500 F2: 100% of options vest on the business day prior to the next annual stockholder meeting following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that will vest 100% on the business day prior to the next annual stockholder meeting following the date of grant, and will be paid in the form of one share of common stock for each restricted stock unit.
F2: 100% of options vest on the business day prior to the next annual stockholder meeting following the date of grant.
HTG MOLECULAR DIAGNOSTICS, INC
Report date September 15, 2022 · Filed September 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.86 · Expires 2032-09-14 | Direct | 8,000 |
Reported balance
After 2022-09-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-09-15 · Grant · Acquired 8,000 · Balance 8,000 F1: The shares will vest on the earlier of September 15, 2023 or the date of the next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares will vest on the earlier of September 15, 2023 or the date of the next annual meeting of stockholders.
SCYNEXIS INC
Report date June 26, 2026 · Filed June 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,577 |
Reported balance
After 2026-06-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-26 · Grant · Acquired 2,875 · Balance 11,577 F1: One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. F2: On May 29, 2026, the common stock of the Issuer underwent a 1-for-8 reverse stock split (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.85 · Expires 2036-06-25 | Direct | 2,875 |
Reported balance
After 2026-06-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-26 · Grant · Acquired 2,875 · Balance 2,875 F3: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
F2: On May 29, 2026, the common stock of the Issuer underwent a 1-for-8 reverse stock split (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.
F3: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2026 Filed Jun 30, 2026 20:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 2,875 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001286338-26-000002 · ownership.xml · derivative · entry 2 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,875 Underlying: Common Stock · 2,875 shares Expires 2036-06-25 F3 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 2,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001286338-26-000002 · ownership.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,577 F1 · shares: One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. F2 · balance_after: On May 29, 2026, the common stock of the Issuer underwent a 1-for-8 reverse stock split (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:13 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option · Derivative | 23,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0000950170-25-091570 · ownership.xml · derivative · entry 2 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2035-06-25 F2 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:13 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-091570 · ownership.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,622 F1 · shares: One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 20:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option · Derivative | 23,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0000950170-24-076200 · ownership.xml · derivative · entry 2 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2034-06-19 F2 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 20:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076200 · ownership.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,622 F1 · shares: One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| June 15, 2023 Filed Jun 21, 2023 00:02 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option · Derivative | 10,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0000950170-23-029041 · ownership.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-14 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| June 15, 2023 Filed Jun 23, 2023 20:10 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-029615 · ownership.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,622 F1 · shares: One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| September 15, 2022 Filed Sep 15, 2022 18:05 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001209191-22-050145 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2032-09-14 F1 · derivative.exercise_date: The shares will vest on the earlier of September 15, 2023 or the date of the next annual meeting of stockholders. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 20:04 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001209191-22-038660 · doc4.xml · derivative · entry 2 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-16 F2 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 20:04 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038660 · doc4.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,622 F1 · shares: One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 17:14 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $6.25 | $0.00 |
DisclosureSEC source: 0001209191-21-052580 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2031-08-17 F1 · derivative.exercise_date: The shares will vest on the earlier of August 18, 2022 or the date of the next annual meeting of stockholders. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 12:29 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001209191-21-041823 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 14:07 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock Warrant · Derivative | 1,600 | Not disclosed Strike: $8.25 | Not disclosed |
DisclosureSEC source: 0001209191-20-064957 · doc4.xml · derivative · entry 3 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2024-06-21 F1 · price: Reflects the purchase on December 21, of 3,200 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant). Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 14:07 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock Warrant · Derivative | 1,600 | Not disclosed Strike: $7.33 | Not disclosed |
DisclosureSEC source: 0001209191-20-064957 · doc4.xml · derivative · entry 2 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2021-12-21 F1 · price: Reflects the purchase on December 21, of 3,200 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant). Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 14:07 UTC | SCYNEXIS INC SCYX · Entity 7194 | PurchaseCommon Stock | 3,200 | $6.25 | $20,000.00 |
DisclosureSEC source: 0001209191-20-064957 · doc4.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,622 F1 · price: Reflects the purchase on December 21, of 3,200 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant). Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 17:06 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001209191-20-047965 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-08-18 F1 · derivative.exercise_date: The shares will vest on the earlier of August 19, 2021 or the date of the next annual meeting of stockholders. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:10 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-20-041737 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-07-05 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| July 06, 2020 Filed Mar 31, 2021 20:03 UTC Amendment | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-21-023759 · doc4a.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-07-05 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 16:24 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001209191-19-046320 · doc4.xml · derivative · entry 2 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-08-13 F1 · derivative.exercise_date: The shares will vest on the earlier of August 14, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 16:24 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046320 · doc4.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,304 Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 17:33 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001209191-19-038196 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-06-17 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 13:06 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001209191-19-001638 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2029-01-01 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| September 11, 2018 Filed Sep 12, 2018 20:04 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantCommon Stock | 2,304 | $4.34 | $9,999.36 |
DisclosureSEC source: 0001209191-18-050732 · doc4.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,804 F1 · shares: The shares were acquired by the Reporting Person pursuant to the Issuer's Amended and Restated Stock Purchase Plan adopted December 1, 2015, as amended January 21, 2016. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 17:23 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001209191-18-047472 · doc4.xml · derivative · entry 2 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-08-14 F1 · derivative.exercise_date: The shares will vest on the earlier of August 15, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 17:23 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-047472 · doc4.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:21 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (right to buy) · Derivative | 19,989 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001209191-18-001739 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,989 Underlying: Common Stock · 19,989 shares Expires 2028-01-01 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant; provided, that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 16:24 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001209191-17-049205 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2027-08-14 F1 · derivative.exercise_date: The shares will vest monthly in equal installments over a one-year period such that the stock option is fully vested on August 15, 2018. Read SEC document |
| May 04, 2017 Filed May 5, 2017 21:09 UTC | ENDOCYTE INC ECYT · Entity 161591 | GrantStock Option (right to buy) · Derivative | 19,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001179110-17-006716 · edgar.xml · derivative · entry 2 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2027-05-04 F2 · derivative.exercise_date: 100% of options vest on the business day prior to the next annual stockholder meeting following the date of grant. Read SEC document |
| May 04, 2017 Filed May 5, 2017 21:09 UTC | ENDOCYTE INC ECYT · Entity 161591 | GrantCommon Stock | 3,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006716 · edgar.xml · nonDerivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 F1 · shares: Represents restricted stock units that will vest 100% on the business day prior to the next annual stockholder meeting following the date of grant, and will be paid in the form of one share of common stock for each restricted stock unit. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 23:16 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (right to buy) · Derivative | 14,499 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001628280-17-000109 · wf-form4_148365818737871.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,499 Underlying: Common Stock · 14,499 shares Expires 2027-01-03 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant; provided, that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.